Stocks That Hit 52-Week Lows On Tuesday
Tuesday's morning session saw 84 companies set new 52-week lows.
Why Bank Shares Are Trading Lower? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Gainers
Provention Bio, Inc. (NASDAQ: PRVB) shares jumped 250.8% to $23.50 after Sanofi announced it will acquire the company for $25 per share in cash.
Why Aridis Pharmaceuticals Shares Are Soaring Today
Aridis Pharmaceuticals Inc (NASDAQ:ARDS) announced preliminary topline results from the Phase 2a study of AR-501 in cystic fibrosis (CF) patients with…
Dow Surges Over 100 Points; World Acceptance Shares Spike Higher
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 100 points on Thursday.
The Dow traded up 0.35% to 33,863.38 while the NASDAQ rose 1.33% to 11,463.77. The S&P 500 also rose, gaining, 0.75% to 4,046.34.
US GDP Rises 2.9% In Q4; Crude Oil Up Over 1%
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 100 points on Thursday.
Following the market opening Thursday, the Dow traded up 0.27% to 33,834.44 while the NASDAQ rose 0.97% to 11,422.61. The S&P 500 also rose, gaining, 0.58% to 4,039.46.
HC Wainwright & Co. Maintains Buy on Aridis Pharmaceuticals, Lowers Price Target to $10
HC Wainwright & Co. analyst Vernon Bernardino maintains Aridis Pharmaceuticals (NASDAQ:ARDS) with a Buy and lowers the price target from $19 to $10.
UPDATE: Aridis Top-Line Results Of The Phase 3 Double-blinded, Superiority Trial Of Ar-301 Primary Outcome Measures Of Safety And Tolerability Of AR-301 Were Achieved
Primary outcome measures of safety and tolerability of AR-301 were achieved. AR-301 intravenous (IV) infusion was well tolerated. Adverse Events (AEs) and Serious Adverse Events (SAEs) reported over the 28-day study period for the single IV infusion were similar across the active and placebo treatment groups, with no SAEs deemed drug-related.
Why Grom Social Enterprises Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) shares surged 85% to $2.2200. Sonoma Pharmaceuticals and EMC Pharma announced Department of Defense DAPA registration for Microcyn(R) Rx products.
12 Health Care Stocks Moving In Tuesday’s Intraday Session
Gainers bioAffinity Technologies (NASDAQ:BIAF) shares increased by 115.1% to $3.42 during Tuesday’s regular session. Trading volume for this…
Aridis Pharmaceuticals Currently Presenting Webinar; ‘New Approaches To Treating Infections In Cystic Fibrosis Patients AR-501 Phase 2 Trial Update’; Shares Spike Lower
https://redchip.zoom.us/webinar/register/WN_WB4K1ES0S1aJzl5ucesN5A